CSS
CKPT

Cubist Systematic Strategies’s Checkpoint Therapeutics CKPT Stock Holding History

Cubist Systematic Strategies’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,488
Closed -$35.8K – 3406
2023
Q2 		$35.8K Buy
+14,488
New +$39.6K ﹤0.01% 3134
2022
Q2 		– Sell
-9,381
Closed -$166K – 4377
2022
Q1 		$166K Buy
9,381
+2,491
+36% +$53.5K ﹤0.01% 3098
2021
Q4 		$214K Buy
+6,890
New +$228K ﹤0.01% 2991
2021
Q3 		– Sell
-1,334
Closed -$39K – 2975
2021
Q2 		$39K Buy
+1,334
New +$37K ﹤0.01% 2812
2020
Q4 		– Sell
-1,855
Closed -$50K – 2573
2020
Q3 		$50K Buy
+1,855
New +$44.5K ﹤0.01% 2367

Other funds holding CKPT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Cubist Systematic Strategies's CKPT Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of Checkpoint Therapeutics (CKPT) in Q3 2023, closing a stake of 14,488 shares — an estimated $35.8K sold.

Cubist Systematic Strategies first reported a position in CKPT in Q3 2020 and held it in 5 quarters. The position peaked at $214K in Q4 2021. 39 funds tracked by Wall St. Rank hold CKPT as of Q3 2023.

  • Cubist Systematic Strategies reported no remaining Checkpoint Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 14,488 Checkpoint Therapeutics shares in Q3 2023, an estimated $35.8K.
  • Cubist Systematic Strategies first reported a position in Checkpoint Therapeutics in Q3 2020 and held it in 5 quarters.
  • Cubist Systematic Strategies's Checkpoint Therapeutics position peaked at $214K in Q4 2021.
  • 39 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.